Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

AR Kansal, SV Sorensen, R Gani, P Robinson, F Pan… - Heart, 2012 - heart.bmj.com
Objective To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant,
versus warfarin and other alternatives for the prevention of stroke and systemic embolism in …
被引用次数：143 相关文章

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation.

AR Kansal, SV Sorensen, R Gani… - Heart (British Cardiac …, 2012 - europepmc.org
Objective To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant,
versus warfarin and other alternatives for the prevention of stroke and systemic embolism in …

[引用][C] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

K AR - Heart, 2012 - cir.nii.ac.jp
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism
in UK patients with atrial fibrillation | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
[HTML] nih.gov

[HTML][HTML] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

AR Kansal, SV Sorensen, R Gani, P Robinson, F Pan… - Heart, 2012 - ncbi.nlm.nih.gov
Objective To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant,
versus warfarin and other alternatives for the prevention of stroke and systemic embolism in …

[引用][C] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

AR KANSAL, SV SORENSEN, R GANI… - Heart (London …, 2012 - pascal-francis.inist.fr
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic
embolism in UK patients with atrial fibrillation CNRS Inist Pascal-Francis CNRS Pascal and …
[PDF] cyberleninka.org

[PDF][PDF] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

AR Kansal, SV Sorensen, R Gani, P Robinson, F Pan… - Heart, 2012 - cyberleninka.org
Objective To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant,
versus warfarin and other alternatives for the prevention of stroke and systemic embolism in …

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

AR Kansal, SV Sorensen, R Gani, P Robinson, F Pan… - Heart, 2012 - search.proquest.com
Objective To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant,
versus warfarin and other alternatives for the prevention of stroke and systemic embolism in …
[PDF] researchgate.net

[PDF][PDF] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

AR Kansal, SV Sorensen, R Gani, P Robinson, F Pan… - Heart, 2012 - researchgate.net
Objective To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant,
versus warfarin and other alternatives for the prevention of stroke and systemic embolism in …

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

AR Kansal, SV Sorensen, R Gani, P Robinson, F Pan… - 2012 - pubmed.ncbi.nlm.nih.gov
Objective To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant,
versus warfarin and other alternatives for the prevention of stroke and systemic embolism in …
[PDF] psu.edu

[PDF][PDF] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

AR Kansal, SV Sorensen, R Gani, P Robinson, F Pan… - Heart, 2012 - Citeseer
Objective To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant,
versus warfarin and other alternatives for the prevention of stroke and systemic embolism in …